ENDORSE: a prognostic model for endocrine therapy response in advanced estrogen-receptor positive breast cancers

Aritro Nath, Adam L. Cohen, Andrea H. Bild
doi: https://doi.org/10.1101/2021.02.03.21251035

Article usage

Article usage: February 2021 to January 2025

AbstractFullPdf
Feb 2021395567
Mar 2021801918
Apr 202193510
May 20215069
Jun 20216048
Jul 202130911
Aug 202122105
Sep 2021251214
Oct 202133520
Nov 20212291345
Dec 2021801015
Jan 202271912
Feb 20223039
Mar 20223797
Apr 202243611
May 202226412
Jun 2022315136
Jul 2022242126
Aug 202233681
Sep 202235647
Oct 202229526
Nov 20221337
Dec 20221778
Jan 20231367
Feb 202318106
Mar 20231460
Apr 20232385
May 202316136
Jun 2023972
Jul 20231056
Aug 202316167
Sep 20231044
Oct 2023682
Nov 202326136
Dec 20231245
Jan 20241323
Feb 20241225
Mar 20241156
Apr 2024540
May 2024446
Jun 2024803
Jul 20246511
Aug 202411311
Sep 20242896
Oct 20247610
Nov 20246014
Dec 20246412
Jan 2025302
Back to top
Posted November 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email
ENDORSE: a prognostic model for endocrine therapy response in advanced estrogen-receptor positive breast cancers
Aritro Nath, Adam L. Cohen, Andrea H. Bild
medRxiv 2021.02.03.21251035; doi: https://doi.org/10.1101/2021.02.03.21251035
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area